Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
1(33.3%)
Phase 3
1(33.3%)
Phase 4
1(33.3%)
3Total
Phase 2(1)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07456085Phase 3Enrolling By Invitation

Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves

Role: lead

NCT07435337Phase 4Recruiting

Effect of Nalbuphine Versus Fentanyl on Hemdoynamic Effects of Laryngoscopy

Role: lead

NCT04218786Phase 2Withdrawn

Effect of Colchicine in Patients With Myocardial Infarction

Role: collaborator

All 3 trials loaded